🇺🇸 FDA
Patent

US 7358222

Preventing airway mucus production by administration of EGF-R antagonists

granted A61KA61K31/00A61P

Quick answer

US patent 7358222 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/00, A61P, A61P11/00, A61P11/02